PI
ATOS icon

PFG Investments’s Atossa Therapeutics ATOS Stock Holding History

PFG Investments’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,450
Closed -$12.8K – 1197
2025
Q4 		$12.8K Buy
1,450
+33
+2% +$417 ﹤0.01% 1146
2025
Q3 		$18.4K Hold
1,417
– – ﹤0.01% 1107
2025
Q2 		$17.6K Buy
1,417
+500
+55% +$5.98K ﹤0.01% 1029
2025
Q1 		$9.25K Sell
917
-76
-8% -$923 ﹤0.01% 1011
2024
Q4 		$14.1K Sell
993
-584
-37% -$11.4K ﹤0.01% 1015
2024
Q3 		$35.9K Hold
1,577
– – ﹤0.01% 983
2024
Q2 		$28.1K Hold
1,577
– – ﹤0.01% 912
2024
Q1 		$42.6K Buy
+1,577
New +$25.3K ﹤0.01% 1002

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFG Investments's ATOS Position: Q1 2026 in Review

PFG Investments sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 1,450 shares — an estimated $12.8K sold.

PFG Investments first reported a position in ATOS in Q1 2024 and held it in 8 quarters. The position peaked at $42.6K in Q1 2024. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • PFG Investments reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • PFG Investments sold 1,450 Atossa Therapeutics shares in Q1 2026, an estimated $12.8K.
  • PFG Investments first reported a position in Atossa Therapeutics in Q1 2024 and held it in 8 quarters.
  • PFG Investments's Atossa Therapeutics position peaked at $42.6K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.